TRB-ONC1
/ Transpire Bio
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 15, 2025
TRB-ONC1 granted U.S. Orphan Drug Designation by the FDA for the treatment of glioblastoma (GBM)
(GlobeNewswire)
Orphan drug • Glioblastoma
1 to 1
Of
1
Go to page
1